Stock Events

Stock Events

Xeris Biopharma (2B30.F) Q4 2023 Earnings

6MarConfirmed

Q4 2023

-0.09

-0.09

-0.08

-0.08

Details

Expected EPS

-0.07843286304

Actual EPS

-0.091744

Surprise EPS

-0.01

Surprise Percent

+16.97%

Description

Xeris Biopharma (2B30.F) has reported earnings of -0.091744 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.